05-May-2011 - Last week non-clinical CRO CIT bought Canadian counterpart LAB Research. Outsourcing-pharma.com spoke with CIT executive chairman Jean-Francois Le Bigot about the deal and the plan going forward.
03-May-2011 - Private equity firms have snapped up CROs over the past year and, with a number of vendors said to be up for sale, the trend is set to continue.
28-Apr-2011 - French contract research organisation (CRO) CIT has completed its acquisition of Canadian counterpart Lab Research.
26-Apr-2011 - Mitsui is to boost its intermediate, API and finished product CMO business and expand in China by buying MBS.
20-Apr-2011 - The top seven CROs will have captured half the market by 2015 as big pharma, including Pfizer, enters into strategic relationships with major players, Jeffries & Company said.
19-Apr-2011 - Outsourcing-Pharma presents a round up of contract services merger and acquisition activity, including deals at Evotec, Vyteris and Avantium Pharma.
13-Apr-2011 - French preclinical contract research organisation (CRO) CIT has said it will buy Canadian counterpart LAB Research in a deal that would rescue the Quebec-based firm from the receivers.
11-Apr-2011 - INC Research plans to make at least one acquisition over the next year as it expands scale, capabilities and geographic reach.
04-Apr-2011 - Michigan, US-based clinical research organisation (CRO), Imperial, has completed the acquisition of clinical trial specialists, D. Anderson & Company for an undisclosed fee.
10-Mar-2011 - The US contract research organization (CRO) Quintiles may look at acquisitions and more ‘strategic partnerships’ after securing a $2.43bn credit facility.
07-Mar-2011 - The incoming Kendle CEO has stressed commitment to early stage and said dramatic changes in the short- to medium-term are unlikely.
02-Mar-2011 - Clinipace Worldwide has bought Regulus Pharmaceutical Consulting to add regulatory expertise to its eClinical contract research services business.
23-Feb-2011 - Consolidation of CMOs will support use of completely outsourced production and distribution networks in the near future.
15-Feb-2011 - US-based Numira Biosciences has expanded its imaging and pre-clinical services portfolio after acquiring the efficacy pharmacology operating unit of Ricerca Biosciences.
14-Feb-2011 - QPS Holdings has acquired Taiwan’s Center of Toxicology and Preclinical Sciences (CTPS), continuing its expansion in the region’s rapidly expanding drug development sector.
01-Feb-2011 - Big pharma outsourcing will become much bolder in the next 12-18 months as companies attempt to “dramatically attack cost structures”, according to the Covance CEO.
24-Jan-2011 - inVentiv Health is to acquire i3 and Campbell Alliance and realign into three operating units: clinical, consulting and commercial.
20-Jan-2011 - CRI Worldwide has acquired Lifetree Clinical Research to double its Phase I capacity and expand therapeutic expertise.
17-Jan-2011 - Dublin, Ireland-based contract research organisation (CRO) Icon has bought Oxford Outcomes, expanding its late Phase research business.
10-Jan-2011 - AMRI has combined its discovery R&D and chemistry units into a single unit it claims will benefit customers.
22-Dec-2010 - The contract service market failed to recover as hoped in 2010 and consequently many companies made cutbacks. Outsourcing-Pharma rounds up five of the most read of 2010.
21-Dec-2010 - Outsourcing-Pharma presents a round up five of our top articles on strategic partnering, which continued apace in 2010, including deals by Covance, PPD and Parexel.
13-Dec-2010 - PRA has relocated its Poland-based early development services and product registration teams into a larger shared office after achieving “solid increases in the placement of clinical studies”.
01-Dec-2010 - US based healthcare distributer, Cardinal Health, has announced the $470m acquisition of privately held healthcare distribution business Zuellig Pharma China, known locally as Yong Yu.
10-Nov-2010 - Kendle recorded a 64 per cent drop in Q3 operating income and expects its strategic review of early stage, which will establish a fair value and consider all options, to...